Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan.
For decades, the United States has led the world in
AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
AbbVie, a leading biopharmaceutical company, has taken a significant step
Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotechnology startup, has successfully raised $3.3 million
Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
BioArctic, a Swedish biotechnology company renowned for its innovative approach
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies
Introduction Overview of UroGen: UroGen Pharma Ltd., headquartered in Princeton,
Marea Biotech Secures $190 Million for Heart Disease Research
Introduction Marea Biotech, a pioneering company in the biotech industry,
Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities
Vector Laboratories and Absolute Biotech have announced a merger, aiming
MOST POPULAR
